Dashboard
Manage Tickers

OABI


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

omniab-lowers-fy2025-sales-guidance-from-20000m-25000m-to-18000m-22000m-vs-21657m-est
OmniAb Lowers FY2025 Sales Guidance from $...
11/04/2025 21:07:06

OmniAb (NASDAQ:OABI) lowers FY2025 sales outlook from $20.000 million-$25.000 million to $18.000 million-$22.000 million vs $21...

omniab-q3-eps-014-inline-sales-2239m-miss-5644m-estimate
OmniAb Q3 EPS $(0.14), Inline, Sales $2.23...
11/04/2025 21:06:23

OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 12.5 pe...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
10/17/2025 21:07:13

omniab-files-for-offering-of-213m-shares-by-selling-stockholders
OmniAb Files For Offering Of 21.3M Shares ...
09/12/2025 20:05:17

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 21:06:39

top-3-health-care-stocks-youll-regret-missing-this-quarter
Top 3 Health Care Stocks You'll Regret Mis...
08/26/2025 11:12:10

omniab-will-sell-2125m-shares-at-140-per-share-or-185-per-share-for-officer-and-director-participation-in-a-private-placement-of-approximately-30m
OmniAb Will Sell 21.25M Shares At $1.40 Pe...
08/25/2025 11:05:05

rbc-capital-maintains-outperform-on-omniab-lowers-price-target-to-3
RBC Capital Maintains Outperform on OmniAb...
08/07/2025 15:11:22

RBC Capital analyst Conor McNamara maintains OmniAb (NASDAQ:OABI) with a Outperform and lowers the price target from $4 to $3.

correction-omniab-q2-eps-015-beats-016-estimate-sales-3897m-miss-5334m-estimate
CORRECTION: OmniAb Q2 EPS $(0.15) Beats $(...
08/06/2025 22:51:45

OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.16) by 4.4...

omniab-affirms-fy2025-sales-guidance-of-20000m-25000m-vs-22970m-est
OmniAb Affirms FY2025 Sales Guidance of $2...
08/06/2025 21:54:44

OmniAb (NASDAQ:OABI) affirms FY2025 sales outlook from $20.000 million-$25.000 million to $20.000 million-$25.000 million vs $2...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

benchmark-reiterates-buy-on-omniab-maintains-6-price-target
Benchmark Reiterates Buy on OmniAb, Mainta...
05/12/2025 15:32:45

Benchmark analyst Robert Wasserman reiterates OmniAb (NASDAQ:OABI) with a Buy and maintains $6 price target.

omniab-affirms-fy2025-sales-guidance-of-2000m-2500m-vs-2289m-est
OmniAb Affirms FY2025 Sales Guidance of $2...
05/08/2025 20:11:12

OmniAb (NASDAQ:OABI) affirms FY2025 sales outlook from $20.00 million-$25.00 million to $20.00 million-$25.00 million vs $22.89...

omniab-q1-eps-017-misses-016-estimate-sales-415m-miss-449m-estimate
OmniAb Q1 EPS $(0.17) Misses $(0.16) Estim...
05/08/2025 20:10:43

OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.16) by 6...

Core News & Articles
Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

Core News & Articles
VERAXA Biotech Joins Forces with OmniAb to...
05/05/2025 06:04:34

Under the terms of the agreement, VERAXA will initiate a novel bispecific antibody drug conjugate program addressing two attrac...

rbc-capital-maintains-outperform-on-omniab-lowers-price-target-to-4
RBC Capital Maintains Outperform on OmniAb...
03/27/2025 15:08:49

RBC Capital analyst Conor McNamara maintains OmniAb (NASDAQ:OABI) with a Outperform and lowers the price target from $7 to $4.

benchmark-maintains-buy-on-omniab-lowers-price-target-to-6
Benchmark Maintains Buy on OmniAb, Lowers ...
03/20/2025 14:25:42

Benchmark analyst Robert Wasserman maintains OmniAb (NASDAQ:OABI) with a Buy and lowers the price target from $8 to $6.

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
03/19/2025 17:06:05

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION